Urgent Angiography Indication Assessment Tool in NSTE ACS

Urgent Angiography Indication Assessment Tool in NSTE ACS Explanation and Clinical Context This tool is designed for patients with non ST segment elevation acute coronary syndrome and helps clinicians identify situations in which an immediate invasive strategy with urgent coronary angiography is appropriate. The 2025 American guideline on acute coronary syndromes states that patients with NSTE ACS who have refractory angina or hemodynamic or electrical instability should undergo an immediate invasive strategy with intent to perform revascularization in order to reduce major adverse cardiovascular events. Patients with these unstable presentations are at particularly high early risk even though they are often under represented in randomized trials.

The guideline describes unstable NSTE ACS as including refractory or recurrent ischemic chest pain despite optimal medical therapy hemodynamic or electrical instability acute pulmonary edema or heart failure and worsening ischemic mitral regurgitation among other features. These clinical findings signal ongoing ischemia or mechanical complications that are unlikely to be controlled by medical therapy alone and therefore support rapid transfer for coronary angiography with a plan for revascularization when feasible. This calculator uses a structured yes or no assessment of seven key unstable features that are consistent with the examples provided in the guideline.

If any of these features are present the output highlights that urgent angiography is indicated and summarizes the number of unstable features identified. If none of the features are present the result emphasizes that urgent angiography is not mandated by unstable features and that an early or delayed invasive strategy should instead be selected based on global ischemic risk bleeding risk comorbid conditions and validated risk scores such as GRACE together with patient preference. The tool is intended to complement rather than replace bedside assessment.

It should not be used in patients with clear ST segment elevation myocardial infarction in whom immediate reperfusion should proceed without delay. In all cases clinicians must consider relative contraindications to angiography such as very high bleeding risk advanced kidney disease limited life expectancy or patient wishes when deciding on the timing and intensity of invasive management. References Rao S and colleagues.

2025 ACC AHA ACEP NAEMSP SCAI Guideline for the Management of Patients With Acute Coronary Syndromes. J Am Coll Cardiol. 2025 Mehta SR Granger CB Boden WE et al.

Early versus delayed invasive intervention in acute coronary syndromes. N Engl J Med. 2009 Jobs A Mehta SR Montalescot G et al.

Optimal timing of an invasive strategy in patients with non ST elevation acute coronary syndrome. Lancet. 2017